Sinaptica

Sinaptica Therapeutics is a clinical-stage electromagnetic therapy company that has pioneered a personalized, non-invasive brain stimulation approach with the potential to revolutionize the treatment of Alzheimer's disease (AD). The company’s investigational SinaptiStim™ – AD system is a medical device designed to deliver personalized electromagnetic treatments that are precisely tailored for each patient. The SinaptiStim™ – AD system combines electromagnetic brain stimulation with powerful proprietary artificial intelligence-derived protocols, brain modeling, and network targeting to create personalized and precise treatment methods.